Becton Dickinson Gross Margin 2012-2026 | BDX
Current and historical gross margin for Becton Dickinson (BDX) over the last 10 years. The current gross profit margin for Becton Dickinson as of March 31, 2026 is %.
| Becton Dickinson Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-03-31 | $21.37B | $10.00B | 46.79% |
| 2025-12-31 | $21.92B | $10.10B | 46.07% |
| 2025-09-30 | $21.84B | $9.93B | 45.44% |
| 2025-06-30 | $21.39B | $9.61B | 44.95% |
| 2025-03-31 | $20.87B | $9.29B | 44.50% |
| 2024-12-31 | $20.64B | $9.33B | 45.22% |
| 2024-09-30 | $20.18B | $9.13B | 45.22% |
| 2024-06-30 | $19.83B | $8.34B | 42.06% |
| 2024-03-31 | $19.72B | $8.13B | 41.25% |
| 2023-12-31 | $19.49B | $8.06B | 41.37% |
| 2023-09-30 | $19.37B | $8.17B | 42.17% |
| 2023-06-30 | $19.05B | $8.55B | 44.87% |
| 2023-03-31 | $18.81B | $8.51B | 45.25% |
| 2022-12-31 | $18.74B | $8.39B | 44.78% |
| 2022-09-30 | $18.87B | $8.48B | 44.92% |
| 2022-06-30 | $18.41B | $8.10B | 43.97% |
| 2022-03-31 | $18.38B | $7.99B | 43.46% |
| 2021-12-31 | $18.53B | $8.12B | 43.81% |
| 2021-09-30 | $19.13B | $8.63B | 45.12% |
| 2021-06-30 | $18.57B | $8.36B | 45.04% |
| 2021-03-31 | $17.82B | $8.07B | 45.26% |
| 2020-12-31 | $17.16B | $7.55B | 44.00% |
| 2020-09-30 | $16.07B | $6.80B | 42.29% |
| 2020-06-30 | $16.92B | $7.64B | 45.15% |
| 2020-03-31 | $17.41B | $8.05B | 46.24% |
| 2019-12-31 | $17.36B | $8.29B | 47.78% |
| 2019-09-30 | $17.29B | $8.29B | 47.94% |
| 2019-06-30 | $17.11B | $8.12B | 47.43% |
| 2019-03-31 | $17.04B | $8.06B | 47.29% |
| 2018-12-31 | $17.06B | $7.69B | 45.06% |
| 2018-09-30 | $15.98B | $7.27B | 45.48% |
| 2018-06-30 | $14.75B | $6.75B | 45.79% |
| 2018-03-31 | $13.50B | $6.24B | 46.21% |
| 2017-12-31 | $12.25B | $6.07B | 49.51% |
| 2017-09-30 | $12.09B | $5.97B | 49.33% |
| 2017-06-30 | $12.16B | $5.94B | 48.86% |
| 2017-03-31 | $12.32B | $5.98B | 48.57% |
| 2016-12-31 | $12.42B | $6.04B | 48.59% |
| 2016-09-30 | $12.48B | $5.99B | 47.99% |
| 2016-06-30 | $12.31B | $5.87B | 47.66% |
| 2016-03-31 | $12.23B | $5.50B | 44.92% |
| 2015-12-31 | $11.22B | $5.06B | 45.09% |
| 2015-09-30 | $10.28B | $4.70B | 45.66% |
| 2015-06-30 | $9.42B | $4.37B | 46.34% |
| 2015-03-31 | $8.46B | $4.30B | 50.87% |
| 2014-12-31 | $8.48B | $4.31B | 50.83% |
| 2014-09-30 | $8.45B | $4.30B | 50.92% |
| 2014-06-30 | $8.35B | $4.29B | 51.36% |
| 2014-03-31 | $8.24B | $4.24B | 51.39% |
| 2013-12-31 | $8.17B | $4.20B | 51.41% |
| 2013-09-30 | $8.05B | $4.17B | 51.79% |
| 2013-06-30 | $7.92B | $4.09B | 51.58% |
| 2013-03-31 | $7.85B | $4.06B | 51.71% |
| 2012-12-31 | $7.78B | $4.03B | 51.79% |
| 2012-09-30 | $7.71B | $3.95B | 51.28% |
| 2012-06-30 | $7.61B | $3.90B | 51.30% |
| 2012-03-31 | $7.58B | $3.90B | 51.44% |
| 2011-12-31 | $7.57B | $3.91B | 51.66% |
| 2011-09-30 | $7.58B | $3.96B | 52.20% |
| 2011-06-30 | $7.34B | $3.85B | 52.39% |
| 2011-03-31 | $7.22B | $3.76B | 52.13% |
| 2010-12-31 | $7.10B | $3.70B | 52.11% |
| 2010-09-30 | $7.12B | $3.70B | 51.87% |
| 2010-06-30 | $7.22B | $3.75B | 51.97% |
| 2010-03-31 | $7.21B | $3.77B | 52.23% |
| 2009-12-31 | $7.14B | $3.73B | 52.23% |
| 2009-09-30 | $6.99B | $3.68B | 52.61% |
| 2009-06-30 | $6.86B | $3.61B | 52.56% |
| 2009-03-31 | $6.89B | $3.59B | 52.11% |
| 2008-12-31 | $6.91B | $3.59B | 51.90% |
| 2008-09-30 | $6.90B | $3.54B | 51.32% |
| 2008-06-30 | $6.88B | $3.52B | 51.18% |
| 2008-03-31 | $6.66B | $3.42B | 51.29% |
| 2007-12-31 | $6.49B | $3.33B | 51.38% |
| 2007-09-30 | $6.28B | $3.25B | 51.73% |
| 2007-06-30 | $6.17B | $3.20B | 51.81% |
| 2007-03-31 | $6.00B | $3.10B | 51.62% |
| 2006-12-31 | $5.85B | $3.01B | 51.49% |
| 2006-09-30 | $5.74B | $2.95B | 51.32% |
| 2006-06-30 | $5.58B | $2.87B | 51.48% |
| 2006-03-31 | $5.51B | $2.83B | 51.41% |
| 2005-12-31 | $5.45B | $2.79B | 51.28% |
| 2005-09-30 | $5.34B | $2.72B | 50.91% |
| 2005-06-30 | $5.29B | $2.67B | 50.47% |
| 2005-03-31 | $5.15B | $2.60B | 50.50% |
| 2004-12-31 | $5.04B | $2.54B | 50.36% |
| 2004-09-30 | $4.94B | $2.43B | 49.32% |
| 2004-06-30 | $4.79B | $2.37B | 49.42% |
| 2004-03-31 | $4.72B | $2.29B | 48.45% |
| 2003-12-31 | $4.60B | $2.22B | 48.24% |
| 2003-09-30 | $4.46B | $2.17B | 48.58% |
| 2003-06-30 | $4.36B | $2.09B | 48.04% |
| 2003-03-31 | $4.19B | $2.03B | 48.54% |
| 2002-12-31 | $4.07B | $1.97B | 48.36% |
| 2002-09-30 | $3.96B | $1.91B | 48.23% |
| 2002-06-30 | $3.94B | $1.91B | 48.40% |
| 2002-03-31 | $3.89B | $1.89B | 48.68% |
| 2001-12-31 | $3.83B | $1.87B | 48.78% |
| 2001-09-30 | $3.75B | $1.83B | 48.93% |
| 2001-06-30 | $3.68B | $1.79B | 48.72% |
| 2001-03-31 | $3.65B | $1.78B | 48.89% |
| 2000-12-31 | $3.62B | $1.77B | 48.88% |
| 2000-09-30 | $3.62B | $1.77B | 48.89% |
| 2000-06-30 | $3.60B | $1.79B | 49.64% |
| 2000-03-31 | $3.56B | $1.74B | 48.86% |
| 1999-12-31 | $3.51B | $1.73B | 49.40% |
| 1999-09-30 | $3.42B | $1.71B | 49.94% |
| 1999-06-30 | $3.36B | $1.68B | 50.01% |
| 1999-03-31 | $3.32B | $1.68B | 50.69% |
| 1998-12-31 | $3.18B | $1.61B | 50.63% |
| 1998-09-30 | $3.12B | $1.58B | 50.56% |
| 1998-06-30 | $3.02B | $1.52B | 50.28% |
| 1998-03-31 | $2.90B | $1.46B | 50.38% |
| 1997-12-31 | $2.86B | $1.43B | 50.12% |
| 1997-09-30 | $2.81B | $1.40B | 49.73% |
| 1997-06-30 | $2.79B | $1.39B | 49.59% |
| 1997-03-31 | $2.78B | $1.37B | 49.37% |
| 1996-12-31 | $2.79B | $1.36B | 48.89% |
| 1996-09-30 | $2.77B | $1.34B | 48.38% |
| 1996-06-30 | $2.76B | $1.33B | 48.17% |
| 1996-03-31 | $2.77B | $1.32B | 47.44% |
| 1995-12-31 | $2.76B | $1.30B | 47.15% |
| 1995-09-30 | $2.71B | $1.28B | 47.05% |
| 1995-06-30 | $2.71B | $1.25B | 46.05% |
| 1995-03-31 | $2.66B | $1.22B | 45.77% |
| 1994-12-31 | $2.60B | $1.19B | 45.59% |
| 1994-09-30 | $2.56B | $1.16B | 45.31% |
| 1994-06-30 | $2.51B | $1.12B | 44.76% |
| 1994-03-31 | $2.48B | $1.11B | 44.78% |
| 1993-12-31 | $2.46B | $1.09B | 44.49% |
| 1993-09-30 | $2.47B | $1.10B | 44.50% |
| 1993-06-30 | $2.48B | $1.11B | 44.72% |
| 1993-03-31 | $2.45B | $1.10B | 44.85% |
| 1992-12-31 | $2.43B | $1.09B | 45.03% |
| 1992-09-30 | $2.37B | $1.06B | 44.93% |
| 1992-06-30 | $2.26B | $1.02B | 45.27% |
| 1992-03-31 | $2.23B | $1.01B | 45.19% |
| 1991-12-31 | $2.19B | $1.00B | 45.55% |
| 1991-09-30 | $2.17B | $1.00B | 45.99% |
| 1991-06-30 | $2.16B | $1.00B | 46.23% |
| 1991-03-31 | $2.10B | $0.97B | 46.31% |
| 1990-12-31 | $2.07B | $0.95B | 45.96% |
| 1990-09-30 | $2.01B | $0.92B | 45.73% |
| 1990-06-30 | $1.95B | $0.89B | 45.61% |
| 1990-03-31 | $1.89B | $0.86B | 45.59% |
| 1989-12-31 | $1.84B | $0.84B | 45.61% |
| 1989-09-30 | $1.81B | $0.83B | 45.75% |
| 1989-06-30 | $1.68B | $0.78B | 46.61% |
| 1989-03-31 | $1.72B | $0.80B | 46.59% |
| 1988-12-31 | $1.72B | $0.80B | 46.57% |
| 1988-09-30 | $1.71B | $0.80B | 46.52% |
| 1988-06-30 | $1.80B | $0.82B | 45.57% |
| 1988-03-31 | $1.71B | $0.78B | 45.73% |
| 1987-12-31 | $1.64B | $0.75B | 46.03% |
| 1987-09-30 | $1.58B | $0.73B | 45.86% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $43.913B | $21.840B |
| Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |